GSK forecasts slower sales growth in 2026
GSK forecasts slower sales growth in 2026
ReutersWed, February 4, 2026 at 7:05 AM UTC
0
FILE PHOTO: GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/File Photo
Feb 4 (Reuters) - GSK on Wednesday forecast sales growth to slow in 2026 in the first outlook presented by new CEO Luke Miels as the drugmaker shifts focus on expanding its pipeline to counter looming patent expiries for its top-selling HIV drugs.
Advertisement
The firm expects revenue to grow 3 % to 5% this year, at constant currency rates, after rising 7% in 2025.
(Reporting by Sri Hari N S, Pushkala Aripaka in Bengaluru, and Bhanvi Satija in London; Editing by Sonia Cheema)
Source: “AOL Money”
